Twist and Ginkgo Join Lilly’s TuneLab to Speed Antibody Discovery With AI and Lab Data
Twist Bioscience and Ginkgo Datapoints join Eli Lilly’s TuneLab to pair lab testing with AI for faster antibody drug discovery.
/ 3 items
#TWST↓
Twist Bioscience Shares Jump on Record Revenue, Raised Guidance and Path to Profitability
Twist Bioscience shares rose after record $118.4M Q3 revenue (+23% YoY), 14th sequential growth quarter, raised FY26 outlook, and path to EBITDA breakeven.
Twist Bioscience Stock Surges Toward $1 Billion Goal as Canaccord Joins Bullish Chorus
Canaccord is bullish on Twist Bioscience, citing AI-driven DNA tech growth, strong revenue gains, and upside to $90 target.